Categories News Press Releases Archives 2024 September August July June May April March February January 2023 December November October September August July June May April March February January 2022 December November October September August July June May April March February January 2021 December November October September August July June May April March February January 2020 December November October September August July June May April March February January 2019 December November October September August July June May April March February January 2018 December November October September August July June May April March February January Jun 27 Fulfilling Our Ambition to Deliver an FDA-Approved Treatment for People Living with Generalized Myasthenia Gravis Read More Share:| | Jun 27 UCB announces U.S. FDA approval of RYSTIGGO® (rozanolixizumab-noli) for the treatment of adults with generalized myasthenia gravis Read More Share:| | Jun 14 How UCB Is Supporting the Mental Health of Patients and Caregivers Read More Share:| | Jun 14 Recognizing Ethical Leadership at UCB Read More Share:| | Jun 08 Employee Spotlight: Natasha Trujillo’s Passion for Advocacy Read More Share:| | Jun 02 Prioritizing Mental Health as a Caregiver to a Child With Dravet Syndrome Read More Share:| | Jun 01 Myasthenia Gravis Awareness Month is the Time to Understand More About the Lived Experiences of the Community Read More Share:| |